IJCRR - Vol 09 Issue 02, January, 2017
The Prevalence of Philadelphia Chromosome in BCR-ABL Positive Chronic Myelogenous Leukemia Cases in North Indian Population
Author: Fatima Bhopalwala Ali1, R.K. Verma2, Mustafa Ali3, Navneet Kumar4
Aim: The aim of my study was to identify the prevalence of Philadelphia chromosome in BCR-ABL positive CML cases in North Indian population. Philadelphia (Ph) chromosome is a specific cytogenetic marker, essentially required for the diagnosis, clinical management and follow up of patients of chronic myelogenous leukemia (CML), which is a myeloproliferative neoplasm of hematopoietic cell. It results from a reciprocal translocation, t (9; 22) (q34; q11.2) in the hematopoietic stem cells. The molecular consequence is the formation of the chimeric BCR ABL1 gene which plays a central role in the development of CML.
Methods: Bone marrow and peripheral blood sample from 66 CML cases were collected from Dept. of Clinical Hematology, KGMU. The samples culture and cytogenetic analysis was done in the Dept. of Anatomy, KGMU.
Results: Out of the total 66 cases, karyograms of 52 cases (78.8%) were obtained. 49 cases (94.2%) showed the presence of Philadelphia chromosome, while 5.8% cases showed normal karyogram. Most common age group showing the presence of Ph+ve CML was 41-50 years (28.6%) followed by patients in 51-60 years group. Majority of cases were males (59.2%). Compared with stage of CML 81.6% of Ph+ve cases were in chronic phase.
Conclusion: Majority of the CML cases were Philadelphia positive, with males more commonly involved. Ph+ve CML was seen commonly above 40 years of age with maximum patients presenting in chronic phase of CML. Our results are at par with research reports published around the world on the Philadelphia chromosome prevalence in CML.
Keywords: Chronic myelogenous leukemia, Philadelphia chromosome, BCR-ABL
Fatima Bhopalwala Ali1, R.K. Verma2, Mustafa Ali3, Navneet Kumar4. The Prevalence of Philadelphia Chromosome in BCR-ABL Positive Chronic Myelogenous Leukemia Cases in North Indian Population International Journal of Current Research and Review. Vol 09 Issue 02, January, 14-19
1. Longo DL, Kasper DL, Jameson JL, Fauci AS, Hauser SL, Loscalzo J, editors. Harrison’s principles of internal medicine. 18th ed. New York: Mcgraw hill; 2012.
2. Cavalli F, Kaye SB, Hansen HH, Armitage JO, Piccart-Gebhart MJ, editors. Textbook of medical oncology. 4th edition. London: Informa Healthcare; 2009.
3. Perrotti D, Jamieson C, Goldman J, et al. Chronic myeloid leukemia: mechanisms of blastic transformation. J Clin Invest. 2010;120(7):2254–2264.
4. Vardiman JW, Melo JV, Baccarani M, Thiele J. Myeloproliferative Neoplasms. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, editors. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th edition. Lyon: IARC Press. 2008:32–37.
5. Pitchford CW, Hettinga AC, Reichard KK. Fluorescence in situ hybridization testing for −5/5q, −7/7q, +8, and del(20q) in primary myelodysplastic syndrome correlates with conventional cytogenetics in the setting of an adequate study. Am J Clin Pathol. 2010;133(2):260–4.
6. Hehlmann R, Hochhaus A, Baccarani M. Chronic myeloid leukaemia. Lancet. 2007;370:342–50.
7. Fabarius A, Leitner A, Hochhaus A, et al. Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IV. Blood. 2011;118(26): 6760-68.
8. Chavan D, Ahmad F, Iyer P, et al. Cytogenetic Investigation in Chronic Myeloid Leukemia: Study from an Indian Population. Asian Pacific J Cancer Prev. 2006;(7):423-426.
9. Anand MS, Verma N, Varma S, et al. Cytogenetic and molecular analysis in adult chronic myelogenous leukemia patients in North India. Indian J Med Res. 2012;135(1):42-48.
10. Shaffer LG, McGowan-Jordan J, Schmid M, editors. ISCN (2013): An International System for Human Cytogenetic Nomenclature. Basel: S. Karger, 2013.
11. Wan TSK. Cancer cytogenetics: methodology revisited. Ann Lab Med. 2014;34:413-425.
12. Boronova I, Bernasovsky I, Bernasovska J, et al. Detection of Philadelphia chromosome in patients with chronic myeloid leukemia from the Presov region in Slovakia(1995-2004). Bratisl Lek Listy. 2007;108(10-11):433-436.
13. Du QF, Liu XL, Song LL, et al. Clinical significance of cytogenetic analysis in chronic myeloid leukemia (with report of 155 cases). Di Yi Jun Yi Da Xue Xue Bao. 2002;22(10):905-7.
14. Deininger MW, Cortes J, Paquette R, et al. The prognosis for patients with chronic myeloid leukemia who have clonal cytogenetic abnormalities in philadelphia chromosome-negative cells. Cancer. 2007;110(7):1509-19.